Abstract
Novel neurotechnologies such as brain-computer interfaces aim to offer new treatment options for those suffering with mental or neurological diseases or defects. At the same time, legal tools to regulate and manage these advancements remain underdeveloped in light of various policy challenges. Soft law mechanisms are likely one valuable tool for early management of the development of BCIs. These mechanisms should be flexible enough to grow with the technology as well as be hardened into binding law if necessary. These softer tools will need to be guided by standards and code of conducts that respect the privacy, agency, identity, and dignity of individuals and communities. Here we review three examples – across intergovernmental, civil society, and standard-setting bodies – illustrating the development of early mechanisms to manage BCIs. While these are important first steps, we argue stakeholders must now look to ways to actively, rather than passively, monitor and evaluate outcomes under these soft legal instruments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.